<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2812223044
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        EMDOX 200 mg Film-coated Tablets
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFPODOXIME
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        55.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharma International Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Med City Pharma
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DD14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cefpodoxime is an antibiotic used to kill bacteria, which cause infection in<br />your body. It belongs to a group of antibiotics called cephalosporins.<br />Your doctor has prescribed <strong>Emdox&reg;</strong> because you have one (or more) of the<br />following types of infection:<br />&bull;&thinsp;Tonsillitis.<br />&bull;&thinsp;Sinusitis<br />&bull;&thinsp;Acute chest infection in patients with chronic bronchititis.<br />&bull;&thinsp;Pneumonia.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take <strong>Emdox&reg;</strong>:<br />&bull;&thinsp;If you are allergic (hypersensitive) to cefpodoxime or other cephalosporins or<br />any of the other ingredients of this medicine.<br />&bull;&thinsp;If you have had a severe allergic reaction to particular antibiotics (penicillins,<br />monobactams and carbapenems) as you may also be allergic to Cefpodoxime.<br />Tell your doctor before you start on Emdox&reg; if you think that this applies to<br />you. You must not be given Emdox&reg;.<br /><strong>Take special care with Emdox&reg;</strong><br />&bull;&thinsp;If you have ever been told that your kidneys do not work very well. Also, if<br />you are having any sort of treatment (like dialysis) for kidney failure. You may<br />take<strong> Emdox&reg;</strong> but you may need a lower dose.<br />&bull;&thinsp;If you have ever had inflammation of your bowel, called colitis or any other<br />severe disease affecting your gut.<br />&bull;&thinsp;This medicine can alter the results of some blood tests (such as crossmatching<br />blood and the coomb&prime;s test). It is important to tell the doctor that you<br />are taking this medicine if you have to have any of these tests.<br />&bull;&thinsp;This medicine can also alter the results of urine tests for sugar (such as<br />Benedict&rsquo;s or Fehling&prime;s tests). If you have diabetes and routinely test your<br />urine, tell your doctor. This is because other tests may have to be used to<br />monitor your diabetes while you are having this medicine.<br />Talk to your doctor or pharmacist if any of the above applies to you.<br /><strong>Taking other medicines</strong><br />Please tell you doctor or pharmacist if you are taking or have recently taken<br />any other medicines, including medicines obtained without a prescription.<br />This medicine can be affected by other medicines that are removed by the<br />kidneys. This is especially if these other medicines also affect how well<br />kidneys work. There are many medicines that can do this, so should check with<br />your doctor or pharmacist before taking this medicine.<br />In particular, tell your doctor or pharmacist if you are taking:<br />&bull;&thinsp;Antacids (used to treat indigestion).<br />&bull;&thinsp;Anti-ulcer agents (used to treat ulcer) such as ranitidine or cimetidine.<br />&bull;&thinsp;Diuretics (used to increase urine flow).<br />&bull;&thinsp;Aminoglycoside antibiotics used to treat infections.<br />&bull;&thinsp;Probenecid (used in the treatment of gout).<br />&bull;&thinsp;Anti-coagulants e.g. warfarin.<br />Antacids and anti-ulcer treatments (such as ranitidine and cimetidine) should<br />be taken 2-3 hours after taking Emdox&reg;. Your doctor knows about these and<br />will alter the treatment if considered necessary.<br />If you require any tests (blood, urine or diagnostic), whilst taking this<br />medicine, please ensure that your doctor knows that you are taking <strong>Emdox&reg;</strong>.<br /><strong>Pregnancy and breast-feeding</strong><br />Tell your doctor before you are given <strong>Emdox&reg;:</strong><br />&bull;&thinsp;If you are pregnant, think you might be pregnant or are planning to become<br />pregnant.<br />&bull;&thinsp;If you are breast feeding.<br />Your doctor will consider the benefit of treating you with Emdox&reg; against the<br />risk to your baby.<br /><strong>Driving and using machines</strong><br />If you are experiencing dizziness after having taken this medicine, you should<br />not drive vehicles or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>Emdox&reg; </strong>exactly as your doctor has told you. You should check with your doctor or pharmacist, if you are not sure.<br /><strong>The usual dose is listed below:<br />Adults and Elderly with no kidney problems:</strong><br />Infections of the sinuses: 200 mg twice daily.<br />Tonsillitis: 100 mg twice daily.<br />Chest infections and Pneumonia: 200 mg twice daily.<br /><strong>Adults with kidney problems:</strong><br />Depending on how serious the kidney problems are, the usual dose of Emdox&reg;<br />for the type of infection you have may need to be given only once a day instead<br />of twice a day or even once every two days. Your doctor will decide how much<br />you need to take.<br />If you are on hemodialysis you will usually be given a dose after each dialysis<br />session. Your doctor will tell you how much to take each time.<br /><strong>How to take:</strong><br />It is important that you take your medicine at the right times of day. You should<br />always take the tablets with food because food helps the tablets to absorb.<br />If you take more Emdox&reg; than you should<br />If you accidentally take too much medicine, contact your doctor or pharmacist<br />who will recommend what action you should take.<br />I<strong>f you forget to take Emdox&reg;</strong><br />If you forget to take a dose of your medicine at the correct time, you should<br />take it as soon as possible. However, if it is almost time for your next dose,<br />skip the missed dose. Do not take a double dose to make up for a forgotten<br />dose. Just take the next dose at the correct time. Carry on as before.</p><p><strong>If you stop taking Emdox&reg;</strong><br />Keep taking your medicine until your doctor has told you to stop. Do not stop<br />taking it just because you feel better. If you stop taking the medicine, your<br />condition may reoccur or get worse.<br />If you have any further questions on the use of this product, ask your doctor or<br />pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines,<strong> Emdox&reg;</strong> can cause side effects, although not everybody gets<br />them. The side effects are listed by frequency.<br /><strong>Conditions you need to look out for</strong><br />The following serious side effects have occurred in a small number of people but<br />their exact frequency is unknown:<br />&bull;&thinsp;Severe allergic reaction. Signs include raised and itchy rash, swelling, sometimes<br />of the face or mouth causing difficulty in breathing.<br />&bull;&thinsp;Skin rash, which may blister, and looks like small targets (central dark spot<br />surrounded by a paler area, with a dark ring around the edge).<br />&bull;&thinsp;A widespread rash with blisters and peeling skin. (These may be signs of<br />Stevens-Johnson syndrome or toxic epidermal necrolysis).<br />All of these reactions need urgent medical attention. If you think you are having<br />any of these types of reaction, stop taking this medicine and contact your doctor or<br />your nearest hospital accident and emergency department.<br /><strong>Common side effects (affecting less than 1 in 10 people) include:</strong><br />&bull;&thinsp;Stomach problems: Bloating, nausea, vomiting, stomach pain, flatulence (wind)<br />and diarrhea. If you have severe diarrhea or if you see blood in your diarrhea you<br />should stop taking this medicine and talk to your doctor immediately.<br />&bull;&thinsp;Eating problems: loss of appetite.<br /><strong>Uncommon side effects (affecting less than 1 in 100 people) include:</strong><br />&bull;&thinsp;Hypersensitivity reactions (These are skin rashes that are less severe allergic<br />reactions than mentioned above, lumpy rash (hives), itching).<br />&bull;&thinsp;Headaches.<br />&bull;&thinsp;Pins and needles.<br />&bull;&thinsp;Dizziness.<br />&bull;&thinsp;Ringing in the ears.<br />&bull;&thinsp;Weakness and a feeling of generally being unwell.<br /><strong>Rare side effects (affecting less than 1 in 1000 people) include:</strong><br />&bull;&thinsp;Changes in blood tests that check how your liver is working.<br />&bull;&thinsp;Anaemia.<br />&bull;&thinsp;Drops in the numbers of blood cells (symptoms can include tiredness, new<br />infections and easy bruising or bleeding).<br />&bull;&thinsp;Increase in some types of white blood cells.<br />&bull;&thinsp;Increase in the numbers of small cells that are needed for clotting of the blood.<br />Very rare side effects (affecting less than 1 in 10 000 people) include:<br />&bull;&thinsp;Anaphylactic reactions (e.g. bronchospasms, purpura and edema of the face and<br />extremities).<br />&bull;&thinsp;Worsening in the kidney function.<br />&bull;&thinsp;Liver damage.<br />&bull;&thinsp;Having a course of cefpodoxime can temporarily increase the chance that you<br />can get infections caused by other sorts of germs. For example, thrush may occur.<br />&bull;&thinsp;A type of anaemia that can be severe and is caused by red blood cells breaking<br />up.<br /><strong>If any of the side effects gets serious, or if you notice any side effects not listed<br />in this leaflet, please tell your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Do not use<strong> Emdox&reg;</strong> after the expiry date (EXP) which is stated on the blister and<br />the carton.<br />The expiry date refers to the last day of that month.<br /><strong>Emdox&reg;</strong> tablets: Store below 30&deg;C.<br />Medicines should not be disposed of via wastewater or household waste. Ask your<br />pharmacist how to dispose of medicines no longer required. These measures will<br />help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is cefpodoxime (proxetil)<br />The other ingredients are Microcrystalline cellulose, silicon dioxide,<br />croscarmellose sodium, sodium starch glycolate, sodium lauryl sulfate, colloidal<br />silicon dioxide, magnesium stearate, Opadry, Yellow iron oxide, PEG.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Emdox® 200 mg Tablets are creamy-off white, oval, normal convex film coated
tablets, engraved with MD on one face, break lined and P2 on the other, packed in
Alu./Alu. blister, intended for oral use.
Pack size: 10 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufactured by : Pharma International Company - Jordan<br />Packed by :Med City Pharma - KSA<br />MAH is : Med City Pharma - KSA<br />Tel: 00966920003288<br />Fax: 00966126358138<br />Mobile: 00966555786968<br />P.O .Box: 42512 - Jeddah 21551<br />E-mail: MD.admin@Axantia.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                03/2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>سيفبودوكسيم هو مضاد حيوي يستعمل للقضاء على البكتيريا، التي تسبب الالتهاب في الجسم.<br />وينتمي إلى مجموعة من المضادات الحيوية التي تعرف بالسيفالوسبورينات.<br />&nbsp;لقد قام طبيبك بوصف <strong>إيمدوكس</strong>&reg;&nbsp;لأنك تعاني من واحد (أو أكثر)&nbsp;من الأنواع التالية من الالتهابات:<br />&bull;التهاب اللوزتين.<br />&bull;التهاب الجيوب الأنفية.<br />&bull;التهاب حاد في الصدر عند المرضى الذين يعانون من التهاب القصبات المزمن.<br />&bull;التهاب رئوي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull;إذا كنت تعاني من تحسس (فرط التحسس) لسيفبودوكسيم أو لأي من المضادات الحيوية الأخرى<br />من مجموعة السيفالوسبورينات أو لأي من المكونات الأخرى في هذا الدواء.<br />&bull;إذا عانيت في السابق من تفاعل تحسسي حاد لمضادات حيوية معينة (البنسيلينات، مونوباكتام<br />وكاربابينيم) حيث قد تعاني أيضا من تحسس لسيفبودوكسيم.<br />&nbsp; أخبر طبيبك قبل بدء تناول <strong>إيمدوكس&reg;&nbsp;</strong>إذا كنت تعتقد أن هذا ينطبق عليك. يجب عدم إعطائك<br /><strong>إيمدوكس&reg;&nbsp;</strong>.<br /><strong>الاحتياطات الخاصة عند تناول</strong> <strong>إيمدوكس&reg;&nbsp;</strong><br />&bull;إذا أخبرت من قبل الطبيب أنك تعاني من قصور في وظيفة الكلى. أيضا، إذا كنت تخضع لأي نوع من أنواع علاج قصور وظيفة الكلى (مثل الديلزة). من الممكن تناول <strong>إيمدوكس&reg;&nbsp;</strong><br />لكن قد تحتاج جرعة أقل.<br />&bull;إذا عانيت في السابق من التهاب في الأمعاء، يعرف بالتهاب القولون أو أي مرض آخر حاد<br />يؤثر على الأمعاء.<br />&bull;قد يغير هذا الدواء من نتائج بعض فحوصات الدم )مثل فحص مطابقة الدم و فحص كومب(. من<br />الضروري أن تخبر طبيبك أنك تتناول هذا الدواء إذا كنت ستخضع لأي من هذه الفحوصات.<br />&bull;قد يغير هذا الدواء أيضا من نتائج فحوصات البول المتعلقة بمستوى السكر (مثل فحص بينيديكت<br />أو فحص فهلينج) إذا كنت تعاني من داء السكري و تخضع لفحص دوري للبول، أخبر طبيبك. هذا<br />لأنه قد يكون من الضروري الخضوع لفحوصات أخرى لمراقبة داء السكري خلال فترة تناولك<br />هذا الدواء.<br />أخبر طبيبك أو الصيدلي إذا كان أي مما ذكر في الأعلى ينطبق عليك.<br /><strong>تناول أدوية أخرى</strong><br />الرجاء إخبار طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى، بما في ذلك<br />الأدوية التي يتم الحصول عليها بدون وصفة طبية.<br />قد تؤثرالأدوية الأخرى التي يتم التخلص منها عن طريق الكلى على طريقة عمل هذا الدواء،<br />وخصوصا إذا كانت هذه الأدوية الأخرى أيضا تؤثر على طريقة عمل الكلى. هناك العديد من<br />الأدوية التي قد تقوم بذلك، لذلك يجب التأكد من طبيبك أو الصيدلي قبل تناول هذا الدواء.<br />بشكل خاص، أخبر طبيبك أو الصيدلي إذا كنت تتناول أي مما يلي:<br />&bull;مضادات الحموضة )تستخدم لعلاج عسر الهضم(.<br />&bull;الأدوية المضادة للقرحة (تستعمل لعلاج القرحة) مثل رانيتيدين أو سيميتيدين.<br />&bull;مدرات البول (تستخدم لزيادة تدفق (إخراج) البول).<br />&bull;المضادات الحيوية من مجموعة أمينوجلايكوسايد التي تستعمل لعلاج الالتهابات.<br />&bull;بروبنيسيد )يستعمل لعلاج النقرس(.<br />&bull;مضادات التجلط مثل الوارفارين.<br />يجب تناول مضادات الحموضة والأدوية المضادة للقرحة )مثل رانيتيدين و سيميتيدين( بعد<br />إن طبيبك يعلم بذلك وسيقوم بتغيير العلاج إذا ادعت الحاجة. .&reg; 3 ساعات من تناول إيمدوكس - 2<br />إذا كنت بحاجة للقيام بأي فحوصات )مثل فحوصات الدم، البول أو الفحوصات التشخيصية(، خلال<br />.&reg; فترة تناول هذا الدواء، الرجاء التأكد من أن طبيبك يعلم بأنك تتناول&nbsp;<strong>إيمدوكس&reg;&nbsp;</strong><br /><strong>الحمل والرضاعة الطبيعية</strong><br />في الحالات التالية: &reg; أخبري طبيبك قبل تناول<strong>إيمدوكس&reg;&nbsp;</strong><br />&bull;إذا كنت حاملا، تعتقدين أنك حاملا أو تخططين للحمل.<br />&bull;إذا كنت مرضعة.<br />سيأخذ الطبيب بعين الاعتبار فوائد علاجك باستعمال <strong>إيمدوكس&reg;&nbsp;</strong>مقارنة بالخطر المحتمل على<br />طفلك.<br /><strong>القيادة واستخدام الآلات</strong><br />إذا شعرت بالدوار بعد تناول هذا الدواء، يجب تجنب قيادة المركبات أو تشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول <strong>إيمدوكس&reg;</strong> دائما كما أخبرك طبيبك تماما. يجب التأكد من طبيبك أو الصيدلي، إذا لم تكن &reg;<br />متأكدا.<br /><strong>الجرعة المعتادة مذكورة في الأسفل:</strong><br /><strong>البالغون و كبار السن الذين لا يعانون من مشاكل في الكلى:</strong><br />التهابات الجيوب الأنفية: 200 ملغم مرتين يوميا.<br />التهاب اللوزتين: 100 ملغم مرتين يوميا.<br />التهابات الصدر والالتهاب الرئوي: 200 ملغم مرتين يوميا.<br /><strong>البالغون الذين يعانون من مشاكل في الكلى:</strong><br />لعلاج نوع الالتهاب الذي &reg; اعتمادا على خطورة مشاكل الكلى، إن الجرعة المعتادة من إيمدوكس<br />تعاني منه قد يكون من الضروري إعطاؤها فقط مرة واحدة يوميا بدلا من مرتين يوميا أو حتى مرة<br />واحدة كل يومين. سيقرر الطبيب الجرعة التي تحتاج لتناولها.<br />إذا كنت تخضع للديلزة الدموية سيتم إعطاؤك عادة جرعة بعد كل جلسة ديلزة. سيخبرك طبيبك ما<br />هي الجرعة في كل مرة.<br /><strong>كيفية استخدامه:</strong><br />من الضروري تناول دوائك في الأوقات الصحيحة من اليوم. يجب تناول الأقراص دائما مع الطعام<br />لأن الطعام يساعد في امتصاص الدواء.<br />إذا قمت بتناول إيمدوكس&nbsp;أكثر مما يجب&nbsp;<br />إذا تناولت أكثر مما يجب من الدواء عن طريق الخطأ، اتصل مع طبيبك أو الصيدلي الذي سيوصيك<br />باتخاذ الإجراء المناسب.<br />&reg; إذا نسيت تناول جرعة <strong>إيمدوكس&reg;</strong><br />إذا نسيت تناول جرعة من دوائك في الوقت المناسب، يجب تناولها في أقرب وقت ممكن. لكن، إذا<br />اقترب موعد الجرعة التالية، اترك الجرعة التي نسيتها. لا تتناول جرعة مضاعفة لتعويض الجرعة<br />التي نسيتها. فقط تناول الجرعة التالية في الوقت المناسب. واستمر كما في السابق.<br />&reg; إذا توقفت عن تناول إيمدوكس<br />استمر في تناول دوائك إلى أن يخبرك طبيبك بالتوقف عن ذلك. لا تتوقف عن تناوله فقط لأنك تشعر<br />بتحسن. إذا توقفت عن تناول الدواء، قد يعود الالتهاب مرة أخرى أو قد يزداد سوءا.<br />إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء، إسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، قد يسبب <strong>إيمدوكس&reg;</strong>&nbsp;آثار جانبية، على الرغم من عدم حدوثها لدى الجميع. تم&nbsp;<br />تصنيف الآثار الجانبية حسب التكرار.<br /><strong>حالات يجب الانتباه لحدوثها</strong><br />إن الآثار الجانبية الخطيرة التالية حصلت عند عدد قليل من الأشخاص لكن تكرار حدوثها الدقيق<br />غير معروف:<br />&bull;تفاعل تحسسي حاد. تشمل العلامات طفح بارز على سطح الجلد ويسبب الحكة، تورم، أحيانا في<br />الوجه أو الفم مما يسبب صعوبة في التنفس.<br />&bull;طفح جلدي، الذي قد يسبب تنفط، ويظهر كبقع صغيرة (بقع ذات مركز داكن محاط بمنطقة أكثر<br />شحوبا محاطة بحلقة داكنة على الأطراف).<br />&bull;طفح واسع الانتشار مصحوبا بتنفط و تقشر الجلد. (قد تكون هذه علامات متلازمة ستيفن جونسون<br />أو تحلل نخري سام في البشرة).<br />تحتاج جميع هذه التفاعلات عناية طبية طارئة. إذا كنت تعتقد بأنك تعاني من أحد أنواع هذه<br />التفاعلات، توقف عن تناول هذا الدواء واتصل مع طبيبك أو قسم الطوارئ والحوادث في أقرب<br />مستشفى.<br /><strong>آثار جانبية شائعة (تؤثر على أقل من 1 من كل 10 أشخاص) تتضمن:</strong><br />&bull;مشاكل في المعدة: انتفاخ البطن، الشعور بالغثيان، قيء، ألم في المعدة، نفخة )ريح( وإسهال. إذا<br />كنت تعاني من إسهال حاد أو إذا لاحظت وجود الدم في الإسهال يجب التوقف عن تناول هذا الدواء<br />و التحدث مع طبيبك فورا.<br />&bull;مشاكل في تناول الطعام: فقدان الشهية.<br /><strong>آثار جانبية غير شائعة (تؤثر على أقل من 1 من كل 100 شخص) تتضمن:</strong><br />&bull;تفاعلات فرط التحسس )تشمل طفح الجلد الذي يكون أقل حدة من تفاعلات التحسس المذكورة في<br />الأعلى، طفح كتلي )شرى(، حكة(.<br />&bull;صداع.<br />&bull;تشوش الحس.<br />&bull;الشعور بالدوار.<br />&bull;رنين في الأذنين.<br />&bull;الشعور بالضعف و الشعور العام بالمرض.<br /><strong>آثار جانبية نادرة (تؤثر على أقل من 1 من كل 1000 شخص) تتضمن:</strong><br />&bull;تغيرات في نتائج فحوصات الدم المتعلقة بصحة وظيفة الكبد.<br />&bull;فقر الدم.<br />&bull;انخفاض في عدد خلايا الدم (قد تتضمن الأعراض الشعور بالتعب، الإصابة بالتهابات جديدة،<br />التعرض للكدمات أوالنزيف بسهولة).<br />&bull;زيادة عدد بعض أنواع خلايا الدم البيضاء.<br />&bull;زيادة عدد خلايا صغيرة ضرورية لتجلط الدم.<br /><strong>آثار جانبية نادرة جدا (تؤثر على أقل من 1 من كل 10000 شخص) تتضمن:</strong><br />&bull;تفاعلات فرط التحسس )مثل تشنج القصبات الهوائية، برفرية أو وذمة في الوجه والأطراف(.<br />&bull;قصور في وظيفة الكلى.<br />&bull;تلف في الكبد.<br />&bull;قد يؤدي تناول سيفبودوكسيم إلى زيادة فرصة الإصابة بالالتهابات الناتجة عن أنواع أخرى من<br />الكائنات الدقيقة بشكل مؤقت، مثلا، قد يحدث مرض القلاع.<br />&bull;أحد أنواع فقر الدم التي قد تكون حادة وينتج عن تحلل خلايا الدم الحمراء.<br /><strong>إذا ازدادت حدة أي من الآثار الجانبية، أو إذا لاحظت حدوث أي آثار جانبية غير مذكورة في هذه<br />النشرة، أخبر طبيبك أو الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول و نظرهم.<br />لا تستخدم <strong>إيمدوكس&reg;&nbsp;</strong>بعد تاريخ انتهاء الصلاحية (EXP)&nbsp;المذكور على الشريط و العلبة الخارجية.<br />تاريخ الانتهاء يشير إلى اليوم الأخير من ذلك الشهر.<br /><strong>إيمدوكس&reg;&nbsp;</strong>أقراص: يحفظ بدرجة حرارة دون 30 &reg;م.<br />يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل<br />الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية<br />البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي سيفبودوكسيم (بروكسيتيل).<br />المكونات الأخرى هي ميكروكريستالين سيليلوز، ثاني أكسيد السيليكون، كروسكارميلوز صوديوم،<br />جليكوليت نشا الصوديوم، صوديوم لوريل سلفات، ثاني أكسيد السيليكون الغروي، مغنيسيوم<br />ستيريت، أوبادري، أكسيد الحديد الأصفر، بولي إيثيلين جلايكول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>أقراص إيمدوكس&reg;200 ملغم</strong> هي أقراص مغلفة ذات لون حليبي إلى بيضاء، بيضاوية الشكل،<br />محدبة، محفور على أحد الأوجه MD , ويحتوي على خط لتقسيمها و P2 على الوجه الآخر، معبأة في&nbsp;<br />أشرطة من ألومنيوم/ ألومنيوم، معدة للاستخدام عن طريق الفم.<br /><strong>حجم العبوة</strong>: 10 أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>تصنيع: الشركة الدولية للدواء - الأردن<br />تعبئة: مدينة الدواء للصناعات الدوائية - الممكلة العربية السعودية<br />مالك رخصة التسويق: مدينة الدواء للصناعات الدوائية - المملكة العربية السعودية<br />هاتف: 00966920003288<br />فاكس: 00966126358138<br />جوال: 00966555786968<br />ص.ب: 42512 - جدة 21551<br />بريد الكتروني: MD.admin@Axantia.com&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            03/2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Emdox® 200 mg Film Coated Tablets.
Cefpodoxime (proxetil) 200 mg Film Coated Tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Emdox® 200 mg Film Coated Tablets: Each tablet contains 200 mg Cefpodoxime (proxetil).
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Emdox® Film Coated Tablets.
Emdox® 200 mg Tablets are creamy-off white, oval, normal convex film coated tablets, engraved with MD on one face, break lined and P2 on the other, packed in Alu./Alu. blister, intended for oral use.
Pack size: 10 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefpodoxime is indicated for the treatment of the following infections when caused by susceptible pathogens&nbsp;in adults:</p><p><strong>&bull; Upper respiratory tract infections - Acute bacterial sinusitis.</strong></p><p>- Tonsillitis [For 100mg Tablets only].</p><p><strong>&bull; Lower respiratory tract infections</strong></p><p>- Acute exacerbation of chronic bronchitis.</p><p>- Bacterial pneumonia - Emdox&reg; might not be suitable option depending on the pathogen involved,&nbsp;<br />Consideration should be given to the official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Route of administration: oral.</p><p>The tablets should be taken with food for optimum absorption.</p><p><strong><u>Adults and adolescents with normal renal function:</u></strong></p><p><strong><em>Upper respiratory tract infections:</em></strong> Acute bacterial sinusitis: 200 mg twice daily.</p><p>Tonsillitis: 100 mg twice daily. [For 100mg Tablets only]</p><p><em><strong>Lower respiratory tract infections:</strong></em></p><p>Acute exacerbation of chronic bronchitis: 200mg twice daily.</p><p>Bacterial pneumonia: 200mg twice daily.</p><p><strong><u>Elderly:</u></strong></p><p>It is not necessary to modify the dose in elderly patients with normal renal function.</p><p><u><strong>Children:</strong></u></p><p>Pediatric formulation of cefpodoxime is available for infants and children.<br /><strong>Hepatic Impairment:</strong></p><p>The dosage does not require modification in cases of hepatic impairment.</p><p><u><strong>Renal Impairment:</strong></u></p><p>The dosage of Emdox&reg; does not require modification if creatinine clearance exceeds 40 ml/min.</p><p>Below this value, pharmacokinetic studies indicate an increase in plasma elimination half-life and the maximum plasma concentrations, and hence the dosage should be adjusted appropriately.</p><table border="1" cellspacing="1" cellpadding="1" style="width:616px"><tbody><tr><td>CREATININE CLEARANCE (ML/MIN)</td><td style="width:363px">&nbsp;</td></tr><tr><td>39-10</td><td style="width:363px">Single dose1 administered every 24 hours instead of twice a day (i.e half of the usual adult dose).</td></tr><tr><td>&lt;10</td><td style="width:363px">Single dose1 administered every 48 hours (i.e quarter of the usual adult dose).</td></tr><tr><td>Haemodialysis Patients</td><td style="width:363px">Single dose1 administered after each dialysis session.</td></tr></tbody></table><p>NOTE: 1 The Single dose is either 100 mg or 200 mg, depending on the type of infection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to cefpodoxime, any other cephalosporins or to any of the excipients.
 • Previous history of immediate and / or severe hypersensitivity reaction (anaphylaxis) to penicillin or other beta-lactam antibiotic.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Emdox&reg;</strong> is not a preferred antibiotic for the treatment of staphylococcal pneumonia and should not be used in the treatment of atypical pneumonia caused by organisms such as Legionella, Mycoplasma and Chlamydia. Cefpodoxime is not recommended for the treatment of pneumonia due to S. pneumoniae .</p><p>As with all beta-lactam antibacterial agents, serious and occasionally fatal hypersensitivity reactions have been reported. In case of severe hypersensitivity reactions, treatment with <strong>Emdox&reg;</strong> must be discontinued immediately and adequate emergency measures must be initiated.</p><p>Before beginning treatment, it should be established whether the patient has a history of severe hypersensitivity reactions to cefpodoxime, to other cephalosporins or to any other type of beta-lactam agent. Caution should be used if <strong>Emdox&reg;</strong> is given to patients with a history of non-severe hypersensitivity to other beta-lactam agents.</p><p>In cases of severe renal insufficiency it may be necessary to reduce the dosage regimen dependent on the creatinine clearance . Antibacterial agent-associated colitis and pseudo-membranous colitis have been reported with nearly all anti-bacterial agents, including cefpodoxime, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea during or subsequent to the administration of cefpodoxime . Discontinuation of therapy with cefpodoxime and the administration of specific treatment for Clostridium difficile should be considered. Medicinal products that inhibit peristalsis should not be given.</p><p><strong>Emdox&reg;</strong> should always be prescribed with caution in patients with a history of gastrointestinal disease, particularly colitis.</p><p>As with all beta-lactam antibiotics, neutropenia and more rarely agranulocytosis may develop particularly during extended treatment. For cases of treatment lasting longer than 10 days, the blood count should be monitored and treatment discontinued if neutropenia is found.</p><p>Cephalosporins may be absorbed onto the surface of red cell membranes and react with antibodies directed against the drug. This can produce a positive Coomb&#39;s test and very rarely, haemolytic anaemia. Cross-reactivity may occur with penicillin for this reaction. Changes in renal function have been observed with cephalosporin antibiotics, particularly when given concurrently with potentially nephrotoxic drugs such as aminoglycosides and/or potential diuretics. In such cases, renal function should be monitored.</p><p>As with other antibiotics, prolonged use of <strong>Emdox&reg;</strong> may result in the overgrowth of non-susceptible organisms (candida and Clostridium difficile), which may require interruption of treatment.</p><p><strong>Interaction with laboratory tests:</strong></p><p>A false positive reaction for glucose in the urine may occur with Benedict&#39;s or Fehling&#39;s solutions or with copper sulphate test tablets, but not with tests based on enzymatic glucose oxidase reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically significant drug interactions have been reported during the course of clinical studies.</p><p>Histamine H2-antagonists and antacids reduce the bioavailability of cefpodoxime. Probenecid reduces the excretion of cephalosporins. Cephalosporins potentially enhance the anticoagulant effect of coumarins and reduce the contraceptive effect of oestrogens.</p><p><u>Oral anticoagulants:</u></p><p>Simultaneous administration of cefpodoxime with warfarin may augment its anti-coagulant effects. There have been many reports of increases in oral anti-coagulant activity in patients receiving antibacterial agents, including cephalosporins. The risk may vary with the underlying infection, age and general status of the patient so that the contribution of the cephalosporins to the increase in INR (international normalised ratio) is difficult to assess. It is recommended that the INR should be monitored frequently during and shortly after co-administration of cefpodoxime with an oral anti-coagulant agent.</p><p>Studies have shown that bioavailability is decreased by approximately 30% when cefpodoxime is administered with drugs which neutralise gastric pH or inhibit acid secretions. Therefore, such drugs as antacids of the mineral type and H2 blockers such as ranitidine, which can cause an increase in gastric pH, should be taken 2 to 3 hours after Cefpodoxime administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy: </u></p><p>There are no or limited amount of data from the use of cefpodoxime in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. Due to the benefit of antibiotic treatment, the use of cefpodoxime may be considered during pregnancy if necessary. Caution should be exercised when prescribing to pregnant women.<br /><u>Lactation:</u></p><p>Cefpodoxime is excreted in breast milk in small amounts. Cefpodoxime may be used during breast-feeding. Continuation of breast-feeding should be questioned in case of diarrhea or mucosal fungus infection in the breastfed infant. The possibility of sensitisation should be borne in mind.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dizziness has been reported during treatment with cefpodoxime and may affect the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions are listed below by system organ class and frequency. Frequencies are defined as:</p><p>Very common (&ge;1/10)</p><p>Common (&ge;1/100 to &lt;1/10)</p><p>Uncommon (&ge;1/1,000 to &lt;1/100)</p><p>Rare (&ge;1/10,000 to &lt;1/1,000)</p><p>Very rare (&lt;1/10,000), not known (cannot be estimated from the available data)</p><p><strong>Blood and lymphatic system disorders</strong></p><p>Rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Haematological disorders such as reduction in haemoglobin, thrombocytosis, thrombocytopenia,&nbsp;leucopenia and eosinophilia<br />Very rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Haemolytic anaemia.<br /><strong>Nervous system disorders</strong><br />Uncommon:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Headache, paraesthesia, dizziness<br /><strong>Ear and labyrinth disorders</strong><br />Uncommon:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Tinnitus<br /><strong>Gastrointestinal disorders</strong><br />Common:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Gastric pressure, nausea, vomiting, abdominal pain, flatulence, diarrhea.<br />Bloody diarrhea can occur as a symptom of enterocolitis.<br />The possibility of pseudomembranous enterocolitis should be considered if severe or persistent diarrhea occurs during or after treatment.<br /><strong>Metabolism and nutrition disorders</strong><br />Common:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Loss of appetite<br /><strong>Immune system disorders</strong><br />Hypersensitivity reactions of all degrees of severity have been observed (see section 4.4).<br />Very rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Anaphylactic reactions, bronchospasm, purpura and angioedema.<br /><strong>Renal and urinary disorders</strong><br />Very rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Slight increases in blood urea and creatinine<br /><strong>Hepato-biliary disorders</strong><br />Rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Transient moderate elevations of ASAT, ALAT and alkaline phosphatase and/or bilirubin. These laboratory abnormalities which may be explained by the infection, may rarely exceed twice the upper limit of the&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; named range and elicit a pattern of liver injury, usually cholestatic and most often asymptomatic.<br />Very rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;liver damage<br /><strong>Skin and subcutaneous tissue disorders</strong><br />Uncommon:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Hypersensitivity mucocutaneous reactions, rash, urticaria, pruritus<br />Very rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Stevens- Johnson syndrome, toxic epidermal necrolysis and erythema multiforme<br /><strong>Infections and infestations</strong><br />There can be multiplication of non-sensitive micro-organisms<br /><strong>General disorders and administration site conditions</strong><br />Uncommon:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Asthenia or malaise</p><p><strong>To report any side effect(s):<br />&bull;Saudi Arabia:</strong><br />The National Pharmacovigilance Center (NPC):<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa<br />&bull;Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the event of overdosage with cefpodoxime, supportive and symptomatic therapy is indicated.</p><p>In cases of overdosage, particularly in patients with renal insufficiency, encephalopathy may occur. The encephalopathy is usually reversible once cefpodoxime plasma levels have fallen.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Beta-lactam antibacterial, a 3rd generation cephalosporin.</p><p>ATC Code: J01DD13</p><p><u>Mode of Action:</u></p><p>Cefpodoxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.</p><p><u>PK/PD relationship</u><strong> </strong></p><p>For cephalosporins, the most important pharmacokinetic-pharmacodynamic index correlating with in vivo efficacy has been shown to be the percentage of the dosing interval that the unbound concentration remains above the minimum inhibitory concentration (MIC) of cefpodoxime for individual target species (i.e. %T&gt;MIC).</p><p><u>Mechanism(s) of resistance:</u></p><p>Resistance to cephalosporins results from a variety of mechanisms:</p><p>1) alteration of the cell-wall permeability of gram-negative bacteria.<br />2) alteration of the penicillin binding proteins (PBPs)</p><p>3) &beta;-lactamase production</p><p>4) bacterial efflux pumps</p><p><u>Break points:</u></p><p>European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoints for MIC testing are presented below. EUCAST clinical MIC breakpoints for cefpodoxime (2011-01-05, v 1.3)</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:234px">Organism</td><td style="width:142px">Susceptible (S) (mg/l)</td><td style="width:122px">Resistant (R) (mg/l)</td></tr><tr><td style="width:234px">Enterobacteriaceae<br />(uncomplicated UTI only)</td><td style="width:142px">&le; 1</td><td style="width:122px">&gt;1&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</td></tr><tr><td style="width:234px">Staphylococcus spp.</td><td style="width:142px">Note1</td><td style="width:122px">Note1</td></tr><tr><td style="width:234px">Streptococcus groups A, B, C and G</td><td style="width:142px">Note2</td><td style="width:122px">Note2</td></tr><tr><td style="width:234px">Streptococcus pneumoniae</td><td style="width:142px">&le; 0.25</td><td style="width:122px">&gt;0.5</td></tr><tr><td style="width:234px">Haemophilus influenzae</td><td style="width:142px">&le; 0.25<br />Note3</td><td style="width:122px">&gt;0.5</td></tr><tr><td style="width:234px">Moraxella catarrhalis</td><td style="width:142px">&le; 0.25<br />Note3</td><td style="width:122px">&gt;0.5</td></tr><tr><td style="width:234px">Neisseria gonorrhoeae</td><td style="width:142px">IE</td><td style="width:122px">IE</td></tr><tr><td style="width:234px">Non-species related breakpoint</td><td style="width:142px">IE</td><td style="width:122px">IE</td></tr></tbody></table><p>1 Susceptibility of staphylococci to cephalosporins is inferred from the cefoxitin susceptibility.</p><p>2 The beta-lactam susceptibility of beta-haemolytic streptococcus groups A, B, C and G is inferred from the penicillin susceptibility.</p><p>3 Strains with MIC values above the susceptible breakpoint are very rare or not yet reported. The identification and antimicrobial susceptibility tests on any such isolate must be repeated and if the result is confirmed the isolate must be sent to a reference laboratory.</p><p>*Insufficient evidence</p><p><strong>Susceptibility:</strong></p><p>The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td>Antibacterial spectrum</td></tr><tr><td><strong>Commonly Susceptible species</strong></td></tr><tr><td><strong>Aerobic Gram positive organisms:</strong></td></tr><tr><td>Staphylococcus aureus (Methicillin-susceptible)</td></tr><tr><td>Streptococcus pyogenes</td></tr><tr><td><em><strong>Aerobic Gram negative organisms:</strong></em></td></tr><tr><td>Haemophilus influenzae</td></tr><tr><td>Moraxella catarrhalis</td></tr><tr><td>Proteus mirabilis%</td></tr><tr><td>Species for which acquired resistance may be a problem</td></tr><tr><td>Aerobic Gram positive organisms</td></tr><tr><td>Streptococcus pneumoniae</td></tr><tr><td>Aerobic Gram negative organisms</td></tr><tr><td>Citrobacter freundi$</td></tr><tr><td>Enterobacter cloacae$</td></tr><tr><td>Escherichia coli%</td></tr><tr><td>Klebsiella pneumoniae%</td></tr><tr><td>Serratia marcescens$</td></tr><tr><td><em><strong>Inherently resistant organisms</strong></em></td></tr><tr><td><em><strong>Aerobic Gram positive organisms</strong></em></td></tr><tr><td>Enterococcus spp.</td></tr><tr><td>Staphylococcus aureus (methicillin resistant)</td></tr><tr><td><strong><em>Aerobic Gram negative organisms</em></strong></td></tr><tr><td>Morganella morganii</td></tr><tr><td>Pseudomonas aeruginosa.</td></tr><tr><td>Others</td></tr><tr><td>Chlamydia spp.</td></tr><tr><td>Chlamydophila spp.</td></tr><tr><td>Legionella pneumophila</td></tr><tr><td>Mycoplasma spp.</td></tr></tbody></table><p>$ natural intermediate susceptibility</p><p>+Resistance rates &gt;50% in at least 1 region</p><p>% ESBL producing species are always resistant&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefpodoxime is taken up in the intestine and is hydrolysed to the active metabolite cefpodoxime. When cefpodoxime proxetil is administered orally to fasting subjects as a tablet corresponding to 100 mg of cefpodoxime, 51.5% is absorbed and absorption is increased by food intake. The volume of distribution is 32.3 L and peak levels of cefpodoxime occur 2 to 3 hrs after dosing. The maximum plasma concentration is 1.2 mg/L and 2.5 mg/L after doses of 100 mg and 200 mg respectively. Following administration of 100 mg and 200 mg twice daily over 14.5 days, the plasma pharmacokinetic parameters of cefpodoxime remain unchanged. Serum protein binding of cefpodoxime, 40% principally to albumin. This binding is non saturable in type.</p><p>Concentrations of cefpodoxime in excess of the minimum inhibitory levels (MIC) for common pathogens can be achieved in lung parenchyma, bronchial mucosa, pleural fluid, tonsils, interstitial fluid and prostate tissue.<br />As the majority of cefpodoxime is eliminated in the urine, the concentration is high. (Concentrations in 0-4, 4-8, 8-12 hr fractions after a single dose exceed MIC90 of common urinary pathogens). Good diffusion of cefpodoxime is also seen into renal tissue, with concentrations above MIC90 of the common urinary pathogens, 3-12 hrs after an administration of a single 200 mg dose (1.6-3.1&mu;g/g). Concentrations of cefpodoxime in the medullary and cortical tissues is similar.</p><p>Studies in healthy volunteers show median concentrations of cefpodoxime in the total ejaculate 6-12 hrs following administration of a single 200 mg dose to be above the MIC90 of N. gonorrhoeae.</p><p>The main route of excretion is renal, 80% is excreted unchanged in the urine, with an elimination half-life of approx 2.4 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data based on conventional studies on acute toxicity, repeated dose toxicity, reproduction toxicity and genotoxicity reveal no special hazard for humans not already considered in other sections of the SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose, silicon dioxide, croscarmellose sodium, sodium starch glycolate, sodium lauryl sulfate, colloidal silicon dioxide, magnesium stearate, Opadry, Yellow iron oxide, PEG.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Emdox&reg; 200 mg Tablets</strong> are creamy-off white, oval, normal convex film coated tablets, engraved with MD on one face, break lined and P2 on the other, packed in Alu./Alu. blisters, intended for oral use.<br /><strong>Pack size:</strong> 10 tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed off in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Med City Pharma – KSA.
Tel: 00966920003288
Fax: 00966126358138
Mobile: 00966555786968
P.O .Box: 42512 - Jeddah 21551
E-mail: MD.admin@axantia.com
Manufacturer:
Pharma International Company
Amman - Jordan
Tel: 00962-6-5158890 / 5157893
Fax: 00962-6-5154753
Email: marketing@pic-jo.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                03/2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>